These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7173720)

  • 1. Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
    Willoughby CP; Aronson JK; Agback H; Bodin NO; Truelove SC
    Gut; 1982 Dec; 23(12):1081-7. PubMed ID: 7173720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of disodium azodisalicylate in healthy subjects. A possible new drug for inflammatory bowel disease.
    van Hogezand RA; van Hees PA; Zwanenburg B; van Rossum JM; van Tongeren JH
    Gastroenterology; 1985 Mar; 88(3):717-22. PubMed ID: 2857146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
    Lauritsen K; Hansen J; Ryde M; Rask-Madsen J
    Gastroenterology; 1984 Jun; 86(6):1496-500. PubMed ID: 6143704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy.
    Sandberg-Gertzén H; Ryde M; Järnerot G
    Scand J Gastroenterol; 1983 Jan; 18(1):107-11. PubMed ID: 6675167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.
    Staerk Laursen L; Stokholm M; Bukhave K; Rask-Madsen J; Lauritsen K
    Gut; 1990 Nov; 31(11):1271-6. PubMed ID: 2253912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
    Lauritsen K; Staerk Laursen L; Bukhave K; Rask-Madsen J
    Gut; 1988 Jul; 29(7):974-82. PubMed ID: 2840367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium azodisalicylate. American College of Gastroenterology Committee on FDA-Related Matters.
    Levinson RA
    Am J Gastroenterol; 1985 Mar; 80(3):203-5. PubMed ID: 2858154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
    Kruis W; Schreiber S; Theuer D; Brandes JW; Schütz E; Howaldt S; Krakamp B; Hämling J; Mönnikes H; Koop I; Stolte M; Pallant D; Ewald U
    Gut; 2001 Dec; 49(6):783-9. PubMed ID: 11709512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of disodium azodisalicylate (olsalazine) and metabolites in urine and faeces stored at different temperatures.
    van Hogezand RA; van Schaik A; van Hees PA; van Tongeren JH
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):261-5. PubMed ID: 3243321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
    Campieri M; Lanfranchi GA; Boschi S; Brignola C; Bazzocchi G; Gionchetti P; Minguzzi MR; Belluzzi A; Labò G
    Gut; 1985 Apr; 26(4):400-5. PubMed ID: 3979912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
    Rijk MC; van Schaik A; van Tongeren JH
    Scand J Gastroenterol; 1988 Jan; 23(1):107-12. PubMed ID: 2894070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L
    Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
    Dew MJ; Ebden P; Kidwai NS; Lee G; Evans BK; Rhodes J
    Br J Clin Pharmacol; 1984 Apr; 17(4):474-6. PubMed ID: 6144318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.
    Bondesen S; Tage-Jensen U; Jacobsen O; Hansen SH; Rasmussen SN; Hvidberg EF
    Eur J Clin Pharmacol; 1986; 31(1):23-6. PubMed ID: 2877884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.